12 Month Price Forecast For CL
Distance to CL Price Forecasts
CL Price Momentum
🤔 Considering Colgate (CL)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 4:34 AM UTC
CL Analyst Ratings & Price Targets
Based on our analysis of 28 Wall Street analysts, CL has a consensus that is bullish. The median price target is $102.00, with forecasts ranging from $83.00 to $120.00. Currently, there are 13 Buy ratings, 8 Hold ratings, and 2 Sell ratings.
With CL currently trading at $87.55, the median price forecast suggests a 16.5% upside. The most optimistic forecast comes from at Deutsche Bank, projecting a 37.1% upside, while Lauren Lieberman at Barclays provides the most conservative target, suggesting a -5.2% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CL Analyst Consensus
CL Price Target Range
Latest CL Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CL.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 17, 2025 | Stifel | Mark Astrachan | Hold | Maintains | $95.00 |
| Jan 17, 2025 | Barclays | Lauren Lieberman | Equal-Weight | Maintains | $83.00 |
| Jan 16, 2025 | JP Morgan | Andrea Teixeira | Overweight | Maintains | $103.00 |
| Jan 16, 2025 | UBS | Peter Grom | Buy | Maintains | $104.00 |
| Jan 8, 2025 | TD Cowen | Robert Moskow | Buy | Maintains | $100.00 |
| Jan 7, 2025 | Wells Fargo | Chris Carey | Underweight | Maintains | $83.00 |
| Jan 6, 2025 | Piper Sandler | Korinne Wolfmeyer | Overweight | Maintains | $112.00 |
| Oct 28, 2024 | Stifel | Mark Astrachan | Hold | Downgrade | $101.00 |
| Oct 28, 2024 | TD Cowen | Robert Moskow | Buy | Maintains | $110.00 |
| Oct 28, 2024 | Wells Fargo | Chris Carey | Underweight | Maintains | $92.00 |
| Oct 11, 2024 | JP Morgan | Andrea Teixeira | Overweight | Maintains | $114.00 |
| Sep 24, 2024 | Piper Sandler | Korinne Wolfmeyer | Overweight | Initiates | $121.00 |
| Sep 16, 2024 | Wells Fargo | Chris Carey | Underweight | Downgrade | $100.00 |
| Sep 9, 2024 | Deutsche Bank | Steve Powers | Hold | Downgrade | $109.00 |
| Sep 4, 2024 | UBS | Peter Grom | Buy | Maintains | $122.00 |
| Jul 30, 2024 | Bernstein | Callum Elliott | Market Perform | Maintains | $103.00 |
| Jul 30, 2024 | TD Cowen | Robert Moskow | Buy | Maintains | $115.00 |
| Jul 29, 2024 | Deutsche Bank | Steve Powers | Buy | Maintains | $107.00 |
| Jul 29, 2024 | Barclays | Lauren Lieberman | Equal-Weight | Maintains | $96.00 |
| Jul 29, 2024 | Morgan Stanley | Dara Mohsenian | Overweight | Maintains | $111.00 |
Stocks Similar to Colgate-Palmolive Co
The following stocks are similar to Colgate based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Colgate-Palmolive Co (CL) Financial Data
Colgate-Palmolive Co has a market capitalization of $72.08B with a P/E ratio of 25.4x. The company generates $20.11B in trailing twelve-month revenue with a 14.3% profit margin.
Revenue growth is +2.4% quarter-over-quarter, while maintaining an operating margin of +21.0% and return on equity of +487.9%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Colgate-Palmolive Co (CL) Company Overview
About Colgate-Palmolive Co
Manufactures and sells consumer products globally.
The company operates through two main segments: Oral, Personal and Home Care, and Pet Nutrition. It generates revenue by selling a wide range of products, including oral care items, personal care products, household cleaners, and pet nutrition products, through traditional and eCommerce retail channels.
Founded in 1806 and headquartered in New York, Colgate-Palmolive has a strong brand portfolio that includes well-known names like Colgate, Palmolive, and Hill's Science Diet. The company's diverse product offerings and established distribution channels position it well in the consumer goods market.
Company Information
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
34,000
CEO
Mr. Noel R. Wallace
Country
United States
IPO Year
1977
Website
www.colgatepalmolive.comColgate-Palmolive Co (CL) Latest News & Analysis
Bloomberg Intelligence highlights 50 firms to watch for 2025, with 14 dividend payers meeting "safer" criteria. Top 10 dividend stocks projected net gains of 11.62% to 48.92%.
The identification of 50 firms with potential catalysts and the focus on dividend safety signals investment opportunities, particularly in the top ten stocks with projected gains.
Colgate-Palmolive Company will host a live webcast for its Q4 and full year 2024 earnings call on January 31, 2025, at 8:30 a.m. ET, with materials available at 7:00 a.m. ET.
Colgate-Palmolive's upcoming earnings call offers insights into financial performance, impacting stock valuation and investor sentiment ahead of potential market reactions.
CL's growth is supported by strong pricing strategies and premium innovation, but macroeconomic challenges and currency issues suggest a need for cautious optimism among investors.
CL's pricing and innovation boost growth prospects, yet macroeconomic issues and currency fluctuations may affect profitability, prompting a careful evaluation of future performance.
Procter & Gamble and Colgate-Palmolive face six new lawsuits over fluoride content in toothpaste and mouth rinse for children, raising potential legal and reputational risks.
The lawsuits could lead to regulatory scrutiny, potential product recalls, or reputational damage for Procter & Gamble and Colgate-Palmolive, impacting their stock prices and investor confidence.
Better Pick CL Stock Or KMB Stock?
8 days agoColgate-Palmolive (NYSE: CL) is favored over Kimberly-Clark (NYSE: KMB), trading at 3.5x trailing revenues compared to KMB's 2.1x.
Colgate-Palmolive's higher revenue multiple suggests stronger market confidence and potential growth compared to Kimberly-Clark, indicating better investment attractiveness.
In December, an investment of $1,200 in Business Development Companies increased annual dividend income by $131, bringing the total to nearly $1,700.
Increased investment in Business Development Companies suggests confidence in their performance, potentially signaling attractive dividend yields and growth opportunities for investors.
Frequently Asked Questions About CL Stock
What is Colgate-Palmolive Co's (CL) stock forecast for 2025?
Based on our analysis of 28 Wall Street analysts, Colgate-Palmolive Co (CL) has a median price target of $102.00. The highest price target is $120.00 and the lowest is $83.00.
Is CL stock a good investment in 2025?
According to current analyst ratings, CL has 13 Buy ratings, 8 Hold ratings, and 2 Sell ratings. The stock is currently trading at $87.55. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for CL stock?
Wall Street analysts predict CL stock could reach $102.00 in the next 12 months. This represents a 16.5% increase from the current price of $87.55. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Colgate-Palmolive Co's business model?
The company operates through two main segments: Oral, Personal and Home Care, and Pet Nutrition. It generates revenue by selling a wide range of products, including oral care items, personal care products, household cleaners, and pet nutrition products, through traditional and eCommerce retail channels.
What is the highest forecasted price for CL Colgate-Palmolive Co?
Price targets from Wall Street analysts for CL are not currently available. The stock is trading at $87.55.
What is the lowest forecasted price for CL Colgate-Palmolive Co?
The lowest price target for CL is $83.00 from Lauren Lieberman at Barclays, which represents a -5.2% decrease from the current price of $87.55.
What is the overall CL consensus from analysts for Colgate-Palmolive Co?
The overall analyst consensus for CL is bullish. Out of 28 Wall Street analysts, 13 rate it as Buy, 8 as Hold, and 2 as Sell, with a median price target of $102.00.
How accurate are CL stock price projections?
Stock price projections, including those for Colgate-Palmolive Co, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
